PRKAA1 and neoplasm: However, based on the well-described negative effect of AMPK on the mTOR pathway in other tissues, it is tempting to speculate whether AMPK activation also promote mTORC1 inhibition in normal thyroid cells, as well in the different tumours derived from the thyroid follicular cell.